626 related articles for article (PubMed ID: 24882425)
1. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
Pearlman DM; Najjar S
Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
[TBL] [Abstract][Full Text] [Related]
2. N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders.
Steiner J; Bogerts B
Schizophr Res; 2015 Mar; 162(1-3):291. PubMed ID: 25600550
[No Abstract] [Full Text] [Related]
3. Response to Steiner and Bogerts on N-methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders.
Pearlman DM; Najjar S
Schizophr Res; 2015 Mar; 162(1-3):292-3. PubMed ID: 25660466
[No Abstract] [Full Text] [Related]
4. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
6. Anti-NMDAR antibodies in new-onset psychosis. Positive results in an HIV-infected patient.
Arboleya S; Clemente A; Deng S; Bedmar M; Salvador I; Herbera P; Cunill V; Vives-Bauza C; Haro JM; Canellas F; Julià MR
Brain Behav Immun; 2016 Aug; 56():56-60. PubMed ID: 26996305
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to the glutamate receptor in mania.
Dickerson F; Stallings C; Vaughan C; Origoni A; Khushalani S; Yolken R
Bipolar Disord; 2012 Aug; 14(5):547-53. PubMed ID: 22672262
[TBL] [Abstract][Full Text] [Related]
8. Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies.
Cullen AE; Palmer-Cooper EC; Hardwick M; Vaggers S; Crowley H; Pollak TA; Lennox BR
Lancet Psychiatry; 2021 Feb; 8(2):109-120. PubMed ID: 33357497
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.
Ando Y; Shimazaki H; Shiota K; Tetsuka S; Nakao K; Shimada T; Kurata K; Kuroda J; Yamashita A; Sato H; Sato M; Eto S; Onishi Y; Tanaka K; Kato S
BMC Psychiatry; 2016 Jul; 16():226. PubMed ID: 27391811
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.
Pathmanandavel K; Starling J; Merheb V; Ramanathan S; Sinmaz N; Dale RC; Brilot F
Biol Psychiatry; 2015 Mar; 77(6):537-47. PubMed ID: 25168608
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies.
Ikura T; Katsuse O; Chiba Y; Takahashi Y; Fujishiro H; Kamada A; Saito T; Hirayasu Y
Neurosci Lett; 2016 Aug; 628():201-6. PubMed ID: 27317996
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.
Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A
Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857
[TBL] [Abstract][Full Text] [Related]
13. Glutamate-Related Antibodies and Peripheral Insulin-Like Growth Factor in Bipolar Disorder and Lithium Prophylaxis.
Ferensztajn-Rochowiak E; Kaczmarek M; Wójcicka M; Kaufman-Szukalska E; Dziuda S; Remlinger-Molenda A; Szeliga-Neymann A; Losy J; Rybakowski JK
Neuropsychobiology; 2019; 77(1):49-56. PubMed ID: 30336492
[TBL] [Abstract][Full Text] [Related]
14. Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis.
Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Del-Ben CM; Louzada-Junior P
Schizophr Res; 2018 Dec; 202():55-63. PubMed ID: 29935886
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of circulating anti-N-methyl-
Tay SH; Fairhurst AM; Mak A
Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis.
Pollak TA; McCormack R; Peakman M; Nicholson TR; David AS
Psychol Med; 2014 Sep; 44(12):2475-87. PubMed ID: 24330811
[TBL] [Abstract][Full Text] [Related]
17. Case report of anti-N-methyl-D-aspartate receptor encephalitis in a middle-aged woman with a long history of major depressive disorder.
Rong X; Xiong Z; Cao B; Chen J; Li M; Li Z
BMC Psychiatry; 2017 Aug; 17(1):320. PubMed ID: 28859632
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
Hara M; Martinez-Hernandez E; Ariño H; Armangué T; Spatola M; Petit-Pedrol M; Saiz A; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2018 Apr; 90(16):e1386-e1394. PubMed ID: 29549218
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
Tong J; Huang J; Luo X; Chen S; Cui Y; An H; Xiu M; Tan S; Wang Z; Yuan Y; Zhang J; Yang F; Li CR; Hong LE; Tan Y
Brain Behav Immun; 2019 Oct; 81():213-219. PubMed ID: 31201848
[TBL] [Abstract][Full Text] [Related]
20. Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.
Dean B; Gibbons AS; Boer S; Uezato A; Meador-Woodruff J; Scarr E; McCullumsmith RE
Aust N Z J Psychiatry; 2016 Mar; 50(3):275-83. PubMed ID: 26013316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
